Female Health Co (FHCO) 1.31 $FHCO
The Female Health Company and Aspen Park Pharmaceuticals Name Members of New Board of Directors, to Serve Upon Completion of Merger
GlobeNewswire - Thu Aug 11, 7:30AM CDT
The Female Health Company (FHC) (NASDAQ:FHCO), and Aspen Park Pharmaceuticals, Inc. (APP) today named the members of the new Board of Directors of the combined company who will begin serving upon completion of their proposed merger. The Board of the combined company, to be called Veru Healthcare Inc., will be comprised of nine members, with three directors named by FHC (O.B. Parrish, David R. Bethune and Mary Margaret Frank, Ph.D.), three directors currently on APP's Board of Directors (Mitchell S. Steiner, M.D., Harry Fisch, M.D., and Elgar Peerschke, who will serve as Chairman) and three new directors (Georges Makhoul, Lucy Lu, M.D., and Mario Eisenberger, M.D.) - below is additional information about each director.
FHCO: 1.31 (+0.01)
The Female Health Company Announces Special Shareholders Meeting Will be Held September 20, 2016
GlobeNewswire - Tue Aug 09, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC), manufacturer of the world's leading female condom, the FC2, today announced that it will hold a special meeting of shareholders on Tuesday, September 20, 2016 to approve matters relating to the proposed merger transaction between FHC and Aspen Park Pharmaceuticals, Inc. (APP).
FHCO: 1.31 (+0.01)
The Female Health Company Comments on Expanded Zika Prevention Guidelines
GlobeNewswire - Thu Aug 04, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC) today commented on updated guidance issued by the Centers for Disease Control and Protection (CDC) to prevent the transmission of the Zika virus. Last week, the CDC recommended the use of condoms (female or male condoms) by all pregnant women with sex partners (male or female) who live in or traveled to an area with Zika. The CDC also said that all other couples in which a partner (male or female) has been in an area with Zika can also reduce the risk of sexual transmission by using condoms.
FHCO: 1.31 (+0.01)
The Female Health Company Reports Fiscal 2016 Third Quarter and First Nine Months Operating Results
GlobeNewswire - Thu Jul 28, 7:30AM CDT
Operating Results for Fiscal 2016 First Nine Months Compared with Prior Year Period:
FHCO: 1.31 (+0.01)
The Female Health Company to Present at LD Micro Invitational Investor Conference on Tuesday, June 7, 2016
GlobeNewswire - Fri Jun 03, 7:30AM CDT
The Female Health Company (FHC) (NASDAQ:FHCO), manufacturer of the world's leading female condom, the FC2, today announced that it will be presenting at the LD MICRO Invitational Investor Conference on Tuesday, June 7, 2016. The conference, which will be held at the Luxe Sunset Bel Air Hotel and located at 11461 Sunset Boulevard in Los Angeles, California, will feature 200 small/micro-cap companies and is expected to host more than 1,000 portfolio managers, research analysts and other investors.
FHCO: 1.31 (+0.01)
Brazilian Ministry of Health to Distribute 100,000 FC2s from The Female Health Company at the 2016 Summer Olympics in Rio de Janeiro
GlobeNewswire - Thu May 26, 9:27AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC) today announced that the Ministry of Health in Brazil will distribute 100,000 of FHC's FC2 Female Condoms to the athletes participating in the 2016 Summer Olympics in Rio de Janeiro.
FHCO: 1.31 (+0.01)
The Female Health Company Donates Female Condoms, to Work with CDC on Education and Training, as Part of STD Awareness Month
GlobeNewswire - Mon May 09, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC) today announced that it has donated FC2 Female Condoms to both the CDC Foundation and UNFPA and pledged education and training efforts as part of its participation in Sexually Transmitted Disease (STD) Awareness Month, which occurs every April. While affecting individuals of all ages, STDs disproportionately impact youth. In fact, the Centers for Disease Control (CDC) estimates that those who are between the ages of 15 and 24 make up just over one quarter of the sexually active population, but account for half of the 20 million STDs that occur in the United States every year.
FHCO: 1.31 (+0.01)
The Female Health Company to Present At the Drexel Hamilton Micro-Cap Investor Forum
GlobeNewswire - Thu May 05, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC) today announced that the company will present at the Drexel Hamilton Micro-Cap Investor Forum on Thursday, May 12, 2016 at 3:30 p.m. ET at Drexel Hamilton's offices in New York City.
FHCO: 1.31 (+0.01)
The Female Health Company Reports Fiscal 2016 Second Quarter and First Half Operating Results
GlobeNewswire - Thu Apr 28, 7:30AM CDT
Highlights for Fiscal 2016 First Half:
FHCO: 1.31 (+0.01)
The Female Health Company to Report Second Quarter Operating Results on Thursday, April 28, 2016
GlobeNewswire - Thu Apr 21, 7:31AM CDT
The Female Health Company (NASDAQ:FHCO) today announced that it will host an investor conference call to discuss its operating results for the second quarter and first half of FY2016 on Thursday, April 28, 2016 at 11:15 a.m. Eastern Time (ET). The Company expects to report its operating results earlier the same day.
FHCO: 1.31 (+0.01)
The Female Health Company Addresses Netherlands House of Representatives
GlobeNewswire - Mon Apr 18, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC or the Company) today announced that on March 18, Denise van Dijk, FHC's Director of Global Market Development, was one of three corporate speakers to address the House of Representatives in the Netherlands.
FHCO: 1.31 (+0.01)
The Female Health Company and Aspen Park Pharmaceuticals to Discuss the Proposed Merger
GlobeNewswire - Wed Apr 13, 8:38AM CDT
The Female Health Company (NASDAQ:FHCO) will host an investor conference call to discuss its proposed merger with Aspen Park Pharmaceuticals, Inc. today, Wednesday, April 13, 2016 at 11:00 a.m. Eastern Time (ET). Mitchell Steiner, M.D., President and CEO of Aspen Park Pharmaceuticals, and President and CEO designee of the combined company, will participate in the call.
FHCO: 1.31 (+0.01)
The Female Health Company Enters into Transformational Merger Agreement with Aspen Park Pharmaceuticals
GlobeNewswire - Wed Apr 06, 7:30AM CDT
Proposed Merger Creates A Leading
FHCO: 1.31 (+0.01)
The Female Health Company/Partners Launch Three New Webinars, Newsletter
GlobeNewswire - Thu Mar 31, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC or the Company) today announced the rollout of three large scale webinars by the FHC Education Team.
FHCO: 1.31 (+0.01)
The Female Health Company Reports Fiscal 2016 First Quarter Operating Results
GlobeNewswire - Tue Feb 02, 7:30AM CST
Highlights:
FHCO: 1.31 (+0.01)
The Female Health Company Announces $10 Million Credit Facility With BMO Harris Bank
GlobeNewswire - Mon Jan 04, 7:30AM CST
The Female Health Company (NASDAQ:FHCO) today announced a new $10 million revolving credit facility with BMO Harris Bank, N.A. The new credit line replaces a smaller credit facility with another lender.
FHCO: 1.31 (+0.01)
The Female Health Company Reports Fourth Quarter and Fiscal Year 2015 Operating Results
GlobeNewswire - Tue Dec 01, 7:30AM CST
61 Million Units Sold in FY2015
FHCO: 1.31 (+0.01)
The Female Health Company to Report FY2015 Operating Results on Tuesday, December 1, 2015
GlobeNewswire - Fri Nov 20, 7:30AM CST
The Female Health Company (NASDAQ:FHCO), today announced that it will host an investor conference call to discuss its operating results for the fourth quarter and fiscal year ended September 30, 2015 on Tuesday, December 1, 2015 at 11:15 a.m. Eastern Time (ET). The Company expects to report its operating results earlier the same day.
FHCO: 1.31 (+0.01)
The Female Health Company to Present at LD MICRO "Main Event" Investor Conference on Thursday, December 3, 2015
GlobeNewswire - Tue Nov 17, 7:30AM CST
The Female Health Company (FHC) (NASDAQ:FHCO), manufacturer of the world's leading female condom, the FC2, today announced that it will be presenting at the LD MICRO "Main Event" Investor Conference on Thursday, December 3, 2015. The conference, which will be held at the Luxe Sunset Bel Air Hotel, which is located at 11461 Sunset Boulevard in Los Angeles, California, will feature 200 small/micro-cap companies and is expected to host more than 1,000 portfolio managers, research analysts, and other investors.
FHCO: 1.31 (+0.01)
The Female Health Company and Aspen Park Pharmaceuticals Name Members of New Board of Directors, to Serve Upon Completion of Merger
GlobeNewswire - Thu Aug 11, 7:30AM CDT
The Female Health Company (FHC) (NASDAQ:FHCO), and Aspen Park Pharmaceuticals, Inc. (APP) today named the members of the new Board of Directors of the combined company who will begin serving upon completion of their proposed merger. The Board of the combined company, to be called Veru Healthcare Inc., will be comprised of nine members, with three directors named by FHC (O.B. Parrish, David R. Bethune and Mary Margaret Frank, Ph.D.), three directors currently on APP's Board of Directors (Mitchell S. Steiner, M.D., Harry Fisch, M.D., and Elgar Peerschke, who will serve as Chairman) and three new directors (Georges Makhoul, Lucy Lu, M.D., and Mario Eisenberger, M.D.) - below is additional information about each director.
FHCO: 1.31 (+0.01)
The Female Health Company Announces Special Shareholders Meeting Will be Held September 20, 2016
GlobeNewswire - Tue Aug 09, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC), manufacturer of the world's leading female condom, the FC2, today announced that it will hold a special meeting of shareholders on Tuesday, September 20, 2016 to approve matters relating to the proposed merger transaction between FHC and Aspen Park Pharmaceuticals, Inc. (APP).
FHCO: 1.31 (+0.01)
The Female Health Company Comments on Expanded Zika Prevention Guidelines
GlobeNewswire - Thu Aug 04, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC) today commented on updated guidance issued by the Centers for Disease Control and Protection (CDC) to prevent the transmission of the Zika virus. Last week, the CDC recommended the use of condoms (female or male condoms) by all pregnant women with sex partners (male or female) who live in or traveled to an area with Zika. The CDC also said that all other couples in which a partner (male or female) has been in an area with Zika can also reduce the risk of sexual transmission by using condoms.
FHCO: 1.31 (+0.01)
The Female Health Company Reports Fiscal 2016 Third Quarter and First Nine Months Operating Results
GlobeNewswire - Thu Jul 28, 7:30AM CDT
Operating Results for Fiscal 2016 First Nine Months Compared with Prior Year Period:
FHCO: 1.31 (+0.01)
The Female Health Company to Present at LD Micro Invitational Investor Conference on Tuesday, June 7, 2016
GlobeNewswire - Fri Jun 03, 7:30AM CDT
The Female Health Company (FHC) (NASDAQ:FHCO), manufacturer of the world's leading female condom, the FC2, today announced that it will be presenting at the LD MICRO Invitational Investor Conference on Tuesday, June 7, 2016. The conference, which will be held at the Luxe Sunset Bel Air Hotel and located at 11461 Sunset Boulevard in Los Angeles, California, will feature 200 small/micro-cap companies and is expected to host more than 1,000 portfolio managers, research analysts and other investors.
FHCO: 1.31 (+0.01)
Brazilian Ministry of Health to Distribute 100,000 FC2s from The Female Health Company at the 2016 Summer Olympics in Rio de Janeiro
GlobeNewswire - Thu May 26, 9:27AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC) today announced that the Ministry of Health in Brazil will distribute 100,000 of FHC's FC2 Female Condoms to the athletes participating in the 2016 Summer Olympics in Rio de Janeiro.
FHCO: 1.31 (+0.01)
The Female Health Company Donates Female Condoms, to Work with CDC on Education and Training, as Part of STD Awareness Month
GlobeNewswire - Mon May 09, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC) today announced that it has donated FC2 Female Condoms to both the CDC Foundation and UNFPA and pledged education and training efforts as part of its participation in Sexually Transmitted Disease (STD) Awareness Month, which occurs every April. While affecting individuals of all ages, STDs disproportionately impact youth. In fact, the Centers for Disease Control (CDC) estimates that those who are between the ages of 15 and 24 make up just over one quarter of the sexually active population, but account for half of the 20 million STDs that occur in the United States every year.
FHCO: 1.31 (+0.01)
The Female Health Company to Present At the Drexel Hamilton Micro-Cap Investor Forum
GlobeNewswire - Thu May 05, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC) today announced that the company will present at the Drexel Hamilton Micro-Cap Investor Forum on Thursday, May 12, 2016 at 3:30 p.m. ET at Drexel Hamilton's offices in New York City.
FHCO: 1.31 (+0.01)
The Female Health Company Reports Fiscal 2016 Second Quarter and First Half Operating Results
GlobeNewswire - Thu Apr 28, 7:30AM CDT
Highlights for Fiscal 2016 First Half:
FHCO: 1.31 (+0.01)
The Female Health Company to Report Second Quarter Operating Results on Thursday, April 28, 2016
GlobeNewswire - Thu Apr 21, 7:31AM CDT
The Female Health Company (NASDAQ:FHCO) today announced that it will host an investor conference call to discuss its operating results for the second quarter and first half of FY2016 on Thursday, April 28, 2016 at 11:15 a.m. Eastern Time (ET). The Company expects to report its operating results earlier the same day.
FHCO: 1.31 (+0.01)
The Female Health Company Addresses Netherlands House of Representatives
GlobeNewswire - Mon Apr 18, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC or the Company) today announced that on March 18, Denise van Dijk, FHC's Director of Global Market Development, was one of three corporate speakers to address the House of Representatives in the Netherlands.
FHCO: 1.31 (+0.01)
The Female Health Company and Aspen Park Pharmaceuticals to Discuss the Proposed Merger
GlobeNewswire - Wed Apr 13, 8:38AM CDT
The Female Health Company (NASDAQ:FHCO) will host an investor conference call to discuss its proposed merger with Aspen Park Pharmaceuticals, Inc. today, Wednesday, April 13, 2016 at 11:00 a.m. Eastern Time (ET). Mitchell Steiner, M.D., President and CEO of Aspen Park Pharmaceuticals, and President and CEO designee of the combined company, will participate in the call.
FHCO: 1.31 (+0.01)
The Female Health Company Enters into Transformational Merger Agreement with Aspen Park Pharmaceuticals
GlobeNewswire - Wed Apr 06, 7:30AM CDT
Proposed Merger Creates A Leading
FHCO: 1.31 (+0.01)
The Female Health Company/Partners Launch Three New Webinars, Newsletter
GlobeNewswire - Thu Mar 31, 7:30AM CDT
The Female Health Company (NASDAQ:FHCO) (FHC or the Company) today announced the rollout of three large scale webinars by the FHC Education Team.
FHCO: 1.31 (+0.01)
The Female Health Company Reports Fiscal 2016 First Quarter Operating Results
GlobeNewswire - Tue Feb 02, 7:30AM CST
Highlights:
FHCO: 1.31 (+0.01)
The Female Health Company Announces $10 Million Credit Facility With BMO Harris Bank
GlobeNewswire - Mon Jan 04, 7:30AM CST
The Female Health Company (NASDAQ:FHCO) today announced a new $10 million revolving credit facility with BMO Harris Bank, N.A. The new credit line replaces a smaller credit facility with another lender.
FHCO: 1.31 (+0.01)
The Female Health Company Reports Fourth Quarter and Fiscal Year 2015 Operating Results
GlobeNewswire - Tue Dec 01, 7:30AM CST
61 Million Units Sold in FY2015
FHCO: 1.31 (+0.01)
The Female Health Company to Report FY2015 Operating Results on Tuesday, December 1, 2015
GlobeNewswire - Fri Nov 20, 7:30AM CST
The Female Health Company (NASDAQ:FHCO), today announced that it will host an investor conference call to discuss its operating results for the fourth quarter and fiscal year ended September 30, 2015 on Tuesday, December 1, 2015 at 11:15 a.m. Eastern Time (ET). The Company expects to report its operating results earlier the same day.
FHCO: 1.31 (+0.01)
The Female Health Company to Present at LD MICRO "Main Event" Investor Conference on Thursday, December 3, 2015
GlobeNewswire - Tue Nov 17, 7:30AM CST
The Female Health Company (FHC) (NASDAQ:FHCO), manufacturer of the world's leading female condom, the FC2, today announced that it will be presenting at the LD MICRO "Main Event" Investor Conference on Thursday, December 3, 2015. The conference, which will be held at the Luxe Sunset Bel Air Hotel, which is located at 11461 Sunset Boulevard in Los Angeles, California, will feature 200 small/micro-cap companies and is expected to host more than 1,000 portfolio managers, research analysts, and other investors.
FHCO: 1.31 (+0.01)
